What is the definition of Gaucher Disease Type 2?

Gaucher disease type 2 is an inherited metabolic disorder in which harmful quantities of a fatty substance called glucocerebroside accumulate in the spleen, liver, lungs, bone marrow, and brain. Symptoms usually develop by 3 months of age and include brain damage, seizures, abnormal eye movements, poor ability to suck and swallow, and enlargement of the liver and spleen. Many children die by 2 to 4 years of age. Gaucher disease type 2 is caused by mutations in the GBA gene. It is inherited in an autosomal recessive pattern. While enzyme replacement therapy is available for some types of Gaucher disease, children with Gaucher disease type 2 generally don't respond to this treatment. Evaluation at a comprehensive center specializing in Gaucher disease and supportive care is appropriate for all affected children. 

What are the alternative names for Gaucher Disease Type 2?

  • GD 2
  • Gaucher disease, infantile cerebral
  • Gaucher disease, acute neuronopathic type
  • Condition: Gaucher Disease and GBA-Parkinson Disease
  • Journal: American journal of hematology
  • Treatment Used: Ambroxol
  • Number of Patients: 41
  • Published —
This study evaluated the safety and effectiveness of ambroxol for patients with Gaucher disease (GD) and GBA-Parkinson disease (GBA-PD).
Clinical Trial
  • Status: Recruiting
  • Participants: 200
  • Start Date: June 12, 2017
A Long-term Follow-up Study of Gaucher Disease
Clinical Trial
  • Status: Recruiting
  • Participants: 1257
  • Start Date: July 27, 2010
Gaucher Disease Outcome Survey (GOS)